Related Experiment Video

Updated: Aug 23, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Antioxidants for the treatment of mild cognitive impairment

P Mecocci1, E Mariani, V Cornacchiola

  • 1Department of Gerontology and Geriatrics, University of Perugia, Italy. mecocci@unipg.it

Neurological Research
|July 22, 2004
PubMed

Insights

Mild cognitive impairment (MCI) is an early sign of Alzheimer's disease (AD). Oxidative stress evaluation is a promising method for identifying individuals at risk and guiding early therapeutic interventions for AD.

Area of Science:

  • Neuroscience
  • Gerontology
  • Biochemistry

Background:

  • Mild cognitive impairment (MCI) is characterized by isolated recent memory deficits.
  • MCI often precedes the development of Alzheimer's disease (AD).
  • Identifying individuals at risk for AD is crucial for early intervention.

Purpose of the Study:

  • To explore the role of oxidative stress in the progression from MCI to AD.
  • To highlight the potential of oxidative stress evaluation as a biomarker for AD risk.
  • To emphasize the importance of targeting early disease phases for therapeutic strategies.

Main Methods:

  • Neuroimaging techniques
  • Neuropsychological assessments
  • Biological markers evaluation, focusing on oxidative stress

Main Results:

  • Oxidative stress is implicated in the early stages of AD.
  • MCI represents a prodromal phase of dementia, making it a key target.
  • Evaluating oxidative stress is gaining traction as a method to identify at-risk individuals.

Conclusions:

  • Oxidative stress is a significant factor in the pathogenesis of MCI and AD.
  • Early detection of oxidative stress may facilitate timely therapeutic interventions.
  • Focusing on the prodromal phase of dementia (MCI) is a promising strategy for AD prevention and treatment.

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...